Literature DB >> 12081720

De novo MECP2 frameshift mutation in a boy with moderate mental retardation, obesity and gynaecomastia.

T Kleefstra1, H G Yntema, A R Oudakker, T Romein, E Sistermans, W Nillessen, H van Bokhoven, B B A de Vries, B C J Hamel.   

Abstract

Rett syndrome (RTT) is an X-linked neurodevelopmental disorder caused by mutations in the MECP2 gene, with apparent lethality in male embryos. However, recent studies indicate that mutations in the MECP2 gene can cause congenital encephalopathy, an Angelman-like phenotype and even nonspecific mental retardation in males. We report on a 10-year-old boy with moderate mental retardation, hypotonia, obesity and gynaecomastia and a de novo 2-bp deletion in the MECP2 gene that resulted in a frameshift and premature stop codon. As some of the clinical features were suggestive of the Prader-Willi syndrome, it might be worthwhile screening for MECP2 mutations in patients with an atypical Prader-Willi phenotype but without the characteristic abnormalities on chromosome 15q. This report contributes to the phenotypic knowledge of male patients with MECP2 mutations. Moreover, this is the first reported male case of a de novo MECP2 mutation.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12081720     DOI: 10.1034/j.1399-0004.2002.610507.x

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  15 in total

Review 1.  Rett syndrome: clinical review and genetic update.

Authors:  L S Weaving; C J Ellaway; J Gécz; J Christodoulou
Journal:  J Med Genet       Date:  2005-01       Impact factor: 6.318

Review 2.  What obesity research tells us about epigenetic mechanisms.

Authors:  Neil A Youngson; Margaret J Morris
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2013-01-05       Impact factor: 6.237

Review 3.  Decoding transcriptional repressor complexes in the adult central nervous system.

Authors:  Megumi Adachi; Lisa M Monteggia
Journal:  Neuropharmacology       Date:  2014-01-10       Impact factor: 5.250

4.  Female Mecp2(+/-) mice display robust behavioral deficits on two different genetic backgrounds providing a framework for pre-clinical studies.

Authors:  Rodney C Samaco; Christopher M McGraw; Christopher S Ward; Yaling Sun; Jeffrey L Neul; Huda Y Zoghbi
Journal:  Hum Mol Genet       Date:  2012-10-01       Impact factor: 6.150

5.  Leptin resistance and obesity in mice with deletion of methyl-CpG-binding protein 2 (MeCP2) in hypothalamic pro-opiomelanocortin (POMC) neurons.

Authors:  Xiaorui Wang; Zsombor Lacza; Yi E Sun; Weiping Han
Journal:  Diabetologia       Date:  2014-01       Impact factor: 10.122

6.  Mecp2 truncation in male mice promotes affiliative social behavior.

Authors:  B L Pearson; E B Defensor; R L H Pobbe; L H L Yamamoto; V J Bolivar; D C Blanchard; R J Blanchard
Journal:  Behav Genet       Date:  2011-09-11       Impact factor: 2.805

Review 7.  MECP2 mutations in males.

Authors:  Laurent Villard
Journal:  J Med Genet       Date:  2007-03-09       Impact factor: 6.318

8.  Adult Phenotypes in Angelman- and Rett-Like Syndromes.

Authors:  M H Willemsen; J H M Rensen; H M J van Schrojenstein-Lantman de Valk; B C J Hamel; T Kleefstra
Journal:  Mol Syndromol       Date:  2012-01-13

Review 9.  CNV and nervous system diseases--what's new?

Authors:  W Gu; J R Lupski
Journal:  Cytogenet Genome Res       Date:  2009-03-11       Impact factor: 1.636

10.  A WW domain binding region in methyl-CpG-binding protein MeCP2: impact on Rett syndrome.

Authors:  Jan P Buschdorf; Wolf H Strätling
Journal:  J Mol Med (Berl)       Date:  2003-11-15       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.